age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
73.99896
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 15,322
| 6,225.7891
| 6,328.29688
| 17
|
white
| 22.699219
| 23
| 0.780884
| 0.649902
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 50
| 30.699219
| 55
| 36
| 35.5
| null | null | 1.299805
| 2.299805
| 122
| null | 105
| 40
| 209
| null | null |
no(M2 and SIP pres)
| 3.094727
| 415
| 1
|
57.43997
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 50,645
| 22,831.8906
| 24,215.5781
| 25.5
|
white
| 35
| 32
| 0.448975
| 0.13797
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
no dnr
| 12
| 78
| 11.099609
| 70
| 20
| 37.89844
| 223.3125
| 2.299805
| null | 1.599854
| 137
| 7.419922
| 102
| 41
| 2,540
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 91
| 1
|
70.45599
|
female
| 1
| 4
|
Coma
|
Coma
| 1
| 11
|
>$50k
| 44
| 52,477
| 15,849.2422
| 21,040.875
| 34
|
black
| 25.699219
| 45
| 0.313965
| 0.241974
| 5
| 0
| 0
|
no
| 0.2
| 0.15
|
dnr after sadm
| 4
| 110
| 15.099609
| 155
| 44
| 36.59375
| 680
| 2.599609
| 0.899902
| 1.599854
| 131
| 7.459961
| 114
| 47
| 15
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
63.88199
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 41
| 178,201
| 23,809.0938
| 25,333.0781
| 47
|
white
| 31.097656
| 52
| 0.394958
| 0.27594
| 15
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 8
| 70
| 7.399414
| 45
| 28
| 36.09375
| null | null | null | 1.5
| 139
| null | 90
| 28
| 1,175
| null | null |
<2 mo. follow-up
| 3.230957
| 8
| 1
|
46.00699
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 14
|
$25-$50k
| 44
| 135,769
| 16,093.7578
| 16,401.4688
| 49
|
white
| 33.296875
| 68
| 0.16098
| 0.079987
| 19
| 0
| 0
|
yes
| 0.05
| 0.05
|
dnr after sadm
| 2
| 45
| 22.699219
| 125
| 28
| 35.19531
| 168
| null | 4.5
| 3.699707
| 143
| 7.259766
| 180
| 55
| 10
| null | null |
<2 mo. follow-up
| 3.269531
| 4
| 1
|
63.07999
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 11,751
| 5,963.4883
| 4,836.85938
| 19
|
white
| 16.597656
| 18
| 0.896973
| 0.827881
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 73
| 11.099609
| 102
| 26
| 36.19531
| null | null | null | 0.899902
| 131
| null | 346
| 12
| 3,150
| null | null | null | 2.264648
| 649
| 0
|
64.34796
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
| null | 0
| 7,934
| 3,826.3965
| 2,599.76953
| 4
|
hispanic
| 21.898438
| 34
| 0.73291
| 0.581909
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 63
| 3.699707
| 136
| 32
| 36.19531
| null | 2.5
| null | 0.799927
| 133
| null | null | 15
| 1,250
| 2
| null | null | 1.838867
| 649
| 0
|
52.02698
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 14
|
>$50k
| 26
| 287,368
| 42,209.5
| 43,078.5938
| 34
|
white
| 39.195313
| 84
| 0.312988
| 0.199982
| 17
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 19
| 112
| 14.398438
| 140
| 34
| 39.19531
| 182.5
| null | null | 1.299805
| 135
| 7.529297
| 279
| 36
| 1,770
| null | 0
|
no(M2 and SIP pres)
| 0
| 201
| 1
|
59.75598
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 14
|
>$50k
| 0
| 29,213
| 14,474.2109
| 11,215.9141
| 8
|
white
| 19.296875
| 20
| 0.802979
| 0.681885
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 6
| 113
| 12.599609
| 135
| 49
| 39.5
| 130
| null | null | 1.399902
| 143
| 7.479492
| 148
| 24
| 1,710
| null | null |
no(M2 and SIP pres)
| 2.734863
| 647
| 0
|
72.80194
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 226,908
| 45,777.5625
| 44,422.8125
| 35.333313
|
white
| 25.699219
| 43
| 0.689941
| 0.5979
| 8
| 1
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 20
| 57
| 6.099609
| 155
| 25
| 37.39844
| 118.65625
| null | 1.799805
| 0.899902
| 131
| 7.419922
| null | 21
| 695
| null | null | null | 2.445313
| 643
| 0
|
73.68695
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 14,124
| 7,226.3828
| 6,628.61719
| 9
|
white
| 24.5
| 24
| 0.500977
| 0.179993
| 1
| 0
| 0
|
metastatic
| 0.01
| 0
|
dnr after sadm
| 2
| 63
| null | 65
| 20
| 36.29688
| null | null | null | 1
| 133
| null | 462
| 18
| 3,600
| null | null |
<2 mo. follow-up
| 3.989258
| 11
| 1
|
70.508
|
female
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 42,089
| 9,950.7969
| 10,467.1562
| 13.5
|
white
| 20.296875
| 20
| 0.720947
| 0.635986
| 4
| 0
| 0
|
yes
| null | null |
dnr before sadm
| -1
| 75
| 9.898438
| 74
| 20
| 36.39844
| null | null | 8.5
| null | 134
| null | null | null | 1,430
| null | null |
<2 mo. follow-up
| 1.982422
| 45
| 1
|
55.50198
|
male
| 0
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 338,671
| 150,056.5
| 157,278.375
| 40.75
|
white
| 29.898438
| 46
| 0.750977
| 0.671997
| 1
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 44
| 58
| 22.296875
| 115
| 44
| 38.09375
| 330
| null | 25.597656
| 3
| 142
| 7.5
| 211
| 136
| 4,520
| null | 0
|
no(M2 and SIP pres)
| 0
| 639
| 0
|
63.94299
|
female
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 26
| 252,684
| 66,653.875
| 63,813.4062
| 34.5
|
hispanic
| 28.796875
| 45
| 0.585938
| 0.47699
| 4
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 34
| 67
| 9.798828
| 96
| 22
| 38.19531
| null | null | 3.399902
| 0.699951
| 133
| null | 181
| 8
| 2,625
| 1
| null | null | 1.166748
| 637
| 0
|
47.47998
|
female
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 339,838
| 66,693.75
| 62,851.2812
| 27.5
|
white
| 27.898438
| 39
| 0.747925
| 0.667969
| 16
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 30
| 62
| 12.5
| 135
| 37
| 38.59375
| 347.5
| null | null | 1.5
| 152
| 7.589844
| 304
| 33
| 2,712
| 0
| null | null | 0.494751
| 636
| 0
|
50.51099
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$25-$50k
| 9
| 131,648
| 43,402.2188
| 27,873.1094
| 23.5
|
white
| 23.796875
| 24
| 0.806885
| 0.74292
| 4
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 25
| 70
| 14.798828
| 82
| 22
| 36.39844
| null | 3.099609
| 4.299805
| 0.799927
| 136
| null | 113
| 15
| 800
| 0
| null | null | 0.494751
| 636
| 0
|
66.771
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 18,716
| 8,287.7969
| 7,270.66797
| 10.5
|
white
| 14.5
| 16
| 0.845947
| 0.659912
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 9
| 82
| 9.699219
| 96
| 24
| 38
| null | null | null | 2.699707
| 138
| null | null | 37
| 4,250
| 0
| null | null | 0.494751
| 487
| 1
|
51.85199
|
male
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 54,700
| 25,739.7344
| 31,346.2969
| 11.333328
|
white
| 28.199219
| 17
| 0.549927
| 0.436951
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
dnr after sadm
| 14
| 52
| 17.898438
| 105
| 26
| 38.69531
| 145.6875
| 2.599609
| 0.899902
| 1.299805
| 136
| 7.519531
| 164
| 23
| 3,800
| 0
| 0
|
<2 mo. follow-up
| 0
| 57
| 1
|
58.63397
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 145,518
| 34,237.9688
| 36,742.8438
| 25.666656
|
hispanic
| 33.296875
| 53
| 0.496948
| 0.378967
| 13
| 0
| 0
|
yes
| 0.75
| 0.75
|
no dnr
| 17
| 65
| 10.398438
| 125
| 24
| 36.59375
| 186.65625
| 2.599609
| 7.199219
| 1.099854
| 143
| 7.479492
| 345
| 54
| 1,690
| 0
| 0
| null | 0
| 572
| 1
|
74.41797
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
>$50k
| 26
| 243,036
| 22,826.3125
| 23,285.8125
| 48
|
white
| 25
| 50
| 0.494995
| 0.376953
| 14
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 8
| 122
| 1.599854
| 65
| 24
| 38.09375
| 248.96875
| null | 10.199219
| 0.799927
| 137
| 7.449219
| 152
| 32
| 5,290
| null | null | null | 2.758301
| 634
| 0
|
60.01398
|
male
| 0
| 15
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 54,862
| 23,652.125
| 28,416.7656
| 12
|
white
| 15.398438
| 20
| 0.844971
| 0.659912
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 15
| 99
| 40.796875
| 120
| 24
| 37.89844
| 254.65625
| null | 4.099609
| 0.799927
| 139
| 7.529297
| 107
| 8
| 3,320
| null | null |
no(M2 and SIP pres)
| 2.57666
| 634
| 0
|
34.53799
|
female
| 1
| 28
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 318,788
| 148,268.875
| 152,781.125
| 28.75
|
hispanic
| 17.296875
| 22
| 0.915894
| 0.85791
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 28
| 72
| 14.099609
| 78
| 22
| 38
| null | null | null | 0.799927
| 138
| null | null | 4
| 1,150
| null | 6
|
<2 mo. follow-up
| 6
| 28
| 1
|
79.25494
|
male
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 194,939
| 77,189.125
| 74,435.875
| 26.5
|
white
| 20.898438
| 17
| 0.777954
| 0.705933
| 3
| 0
| 1
|
no
| 0.9
| 0.9
|
dnr after sadm
| 8
| 100
| 15.898438
| 106
| 14
| 36.39844
| 90
| null | 0.5
| 1
| 135
| 7.459961
| 177
| 15
| 1,200
| null | null | null | 4.164063
| 411
| 1
|
59.409
|
male
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 618,719
| 256,636.625
| 225,256.125
| 49.5
|
white
| 31.898438
| 58
| 0.674927
| 0.579956
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 36
| 62
| 31.699219
| 115
| 10
| 35.79688
| 168
| null | 2.699707
| 2.599609
| 138
| 7.419922
| 96
| 29
| 3,240
| null | null | null | 2.714844
| 628
| 0
|
46.31598
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 123,254
| 43,014.375
| 47,108.5312
| 48.5
|
black
| 27.296875
| 46
| 0.809937
| 0.746948
| 2
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 11
| 67
| 28.398438
| 115
| 40
| 38.29688
| 360
| null | null | 1.899902
| 137
| 7.439453
| 207
| 84
| 2,360
| null | null | null | 2.416504
| 404
| 1
|
73.10895
|
female
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 41
| 258,088
| 88,220.75
| 105,923.562
| 47.666657
|
asian
| 44.5
| 63
| 0.058998
| 0.019997
| 4
| 1
| 0
|
no
| 0.4
| 0.25
|
no dnr
| 23
| 78
| 11
| 116
| 24
| 38.39844
| null | 3.199707
| 1.699951
| 1.099854
| 138
| null | 142
| 8
| 850
| null | null |
<2 mo. follow-up
| 3.595215
| 23
| 1
|
72.28699
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
| null | 41
| 235,312
| 20,672.3125
| 21,320.125
| 51
|
white
| 36.796875
| 83
| 0.178986
| 0.091995
| 14
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 69
| 4.899414
| 72
| 14
| 37.79688
| null | 2.899902
| 3.399902
| 0.599976
| 135
| null | 93
| 6
| 1,950
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
51.72897
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 11,742
| 6,274.8945
| 5,124.20703
| 18
|
white
| 16.5
| 20
| 0.919922
| 0.863892
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 6
| 107
| 11.099609
| 55
| 10
| 36.39844
| 365
| 2.299805
| 1.099854
| 0.799927
| 132
| 7.459961
| 148
| 14
| 2,655
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 626
| 0
|
52.89499
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 18
|
>$50k
| 100
| 110,588
| 39,434.4688
| 48,186.0938
| 38
|
white
| 31
| 58
| 0.286987
| 0.176971
| 1
| 0
| 0
|
no
| 0.1
| 0.1
|
no dnr
| 15
| 55
| 11.099609
| 105
| 10
| 38.5
| 250
| 3
| 4.5
| 3.599609
| 148
| 7.539062
| 212
| 57
| 3,988
| null | 0
|
no(M2 and SIP pres)
| 0
| 625
| 0
|
44.31799
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 11
|
$11-$25k
| 0
| 500,747
| 45,473.6562
| 39,775.9688
| 28.75
|
white
| 26.296875
| 48
| 0.781982
| 0.710938
| 23
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 27
| 72
| 27
| 145
| 40
| 38.79688
| 202
| null | 1.199951
| 0.599976
| 136
| 7.389648
| null | 10
| 4,580
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 132
| 1
|
75.87695
|
male
| 0
| 35
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 247,610
| 92,767.625
| 104,459.875
| 34.25
|
white
| 25.398438
| 55
| 0.718994
| 0.562988
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 12
| 35
| 17.296875
| 185
| 10
| 37.69531
| 245
| null | null | 3.899902
| 133
| 7.369141
| 186
| 46
| 3,790
| null | null | null | 2.962402
| 406
| 1
|
69.46198
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 15
|
$25-$50k
| 0
| 156,624
| 50,043.9688
| 50,702.4062
| 35.666657
|
white
| 36.796875
| 63
| 0.471985
| 0.352966
| 3
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 16
| 156
| 112.1875
| 135
| 35
| 38.29688
| 100
| null | null | 3.5
| 139
| 7.279297
| null | 73
| 0
| null | null |
no(M2 and SIP pres)
| 2.757813
| 622
| 0
|
42.44998
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 10,409
| 4,667.8398
| 5,180.37891
| 12
|
white
| 20.5
| 22
| 0.691895
| 0.401978
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
no dnr
| 3
| 70
| 7
| 100
| 26
| 35.89844
| null | 4
| 0.899902
| 1.199951
| 136
| null | 104
| 13
| 2,400
| null | null |
<2 mo. follow-up
| 2.447754
| 38
| 1
|
66.98999
|
female
| 0
| 85
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 501,448
| null | null | 44.5
|
white
| 23
| 33
| 0.741943
| 0.660889
| 1
| 1
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 85
| 67
| 35.695313
| 130
| 28
| 38.59375
| 345.6875
| 3.199707
| 2.399902
| 4.5
| 134
| 7.519531
| null | 166
| 5,435
| null | null | null | 2.827148
| 385
| 1
|
63.36798
|
male
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 294,992
| 85,296
| 80,205.5625
| 40.5
|
white
| 29.5
| 48
| 0.507935
| 0.390991
| 5
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 33
| 115
| 11.199219
| 55
| 26
| 36.39844
| null | 2.399902
| 10.298828
| 1
| 138
| null | 140
| 49
| 2,960
| null | 0
|
no(M2 and SIP pres)
| 0
| 618
| 0
|
61.741
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 14
|
$25-$50k
| 37
| 337,918
| 41,536.5
| 47,599.1562
| 49
|
white
| 41.59375
| 43
| 0.14798
| 0.070999
| 11
| 1
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 10
| 63
| 11.798828
| 155
| 25
| 38
| 173
| null | null | 1.299805
| 134
| 7.289062
| 188
| 24
| 3,185
| null | null |
<2 mo. follow-up
| 3.759766
| 10
| 1
|
68.23297
|
male
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 110,698
| 44,902.375
| 38,490.7188
| 31.666656
|
white
| 24.796875
| 51
| 0.675903
| 0.580933
| 1
| 0
| 0
|
yes
| 0.5
| 0.125
|
no dnr
| 16
| 67
| 5.599609
| 125
| 23
| 38
| 107.04688
| 3.899902
| 4.199219
| 3.299805
| 139
| 7.399414
| 231
| 42
| 990
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 196
| 1
|
70.04199
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 22,080
| 9,438.75
| 11,645.9297
| 11
|
white
| 13
| 9
| 0.856934
| 0.681885
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 8
| 115
| 11.699219
| 112
| 24
| 36.79688
| null | null | null | 0.699951
| 138
| null | null | 7
| 570
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 615
| 0
|
71.36798
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 86,494
| 31,125.2344
| 32,541.3125
| 31.5
|
white
| 37.695313
| 57
| 0.431946
| 0.312988
| 1
| 0
| 0
|
no
| 0.2
| 0.9
|
dnr after sadm
| 9
| 70
| 7
| 110
| 14
| 36.5
| 373.3125
| null | 1.699951
| 2.099609
| 137
| 7.329102
| 69
| 110
| 2,210
| null | null |
<2 mo. follow-up
| 2.898926
| 9
| 1
|
43.25497
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 15
|
$25-$50k
| 26
| 186,516
| 22,284.4531
| 21,458.2969
| 21
|
white
| 30.199219
| 42
| 0.640991
| 0.539917
| 9
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 11
| 62
| 14.699219
| 125
| 26
| 38.59375
| 173.3125
| null | 2.299805
| 1.899902
| 145
| 7.429688
| 241
| 38
| 1,926
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 614
| 0
|
73.90594
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 2
| null | null | 26
| 12,433
| 5,055.2578
| 7,972.87891
| 21
|
white
| 35.195313
| 15
| 0.240997
| 0.029999
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.5
|
dnr after sadm
| 3
| 62
| 15.398438
| 75
| 6
| 35.39844
| 87
| 2.399902
| 28.097656
| 1.399902
| 130
| 7.439453
| 145
| 22
| 3,695
| null | null |
<2 mo. follow-up
| 2.93457
| 33
| 1
|
59.19498
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null |
$11-$25k
| 0
| 31,431
| 13,725.5938
| 14,902.5391
| 27.5
|
white
| 33.796875
| 38
| 0.669922
| 0.496948
| 1
| 1
| 0
|
no
| 0.6
| 0.3
|
no dnr
| 8
| 140
| 15.099609
| 110
| 50
| 38
| 193.3125
| null | null | 1.199951
| 142
| 7.549805
| 160
| 22
| 3,355
| 5
| 4
|
adl>=4 (>=5 if sur)
| 4
| 85
| 1
|
70.81195
|
female
| 1
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 37
| 213,777
| 75,374.125
| 87,726.4375
| 38.5
|
white
| 21.796875
| 26
| 0.647949
| 0.547974
| 1
| 0
| 0
|
yes
| 0.8
| 0.65
|
dnr after sadm
| 7
| 115
| 10.5
| 106
| 24
| 38.5
| null | 3.899902
| 1
| 1
| 134
| null | 82
| 9
| 2,950
| null | 2
|
<2 mo. follow-up
| 2
| 27
| 1
|
73.98499
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$11-$25k
| 9
| 140,801
| 19,539.7812
| 16,611.9531
| 26
|
black
| 17.796875
| 13
| 0.796997
| 0.72998
| 8
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 57
| 34.195313
| 110
| 24
| 35.69531
| 165.28125
| 3.099609
| 3
| 3.299805
| 133
| 7.469727
| 70
| 54
| 4,600
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 612
| 0
|
70.41797
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 14
| null | 0
| 22,418
| 10,673.7266
| 12,543.1484
| 8
|
hispanic
| 14.898438
| 17
| 0.834961
| 0.638916
| 1
| 0
| 0
|
metastatic
| 1
| 0.95
|
no dnr
| 8
| 71
| 15
| 80
| 24
| 35.79688
| 120
| null | 4.099609
| 1.699951
| 135
| 7.379883
| 131
| 67
| 1,304
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 612
| 0
|
79.93195
|
female
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 18
|
under $11k
| 26
| 207,417
| 67,940.125
| 75,389.4375
| 36.666657
|
white
| 17.296875
| 20
| 0.750977
| 0.672974
| 4
| 1
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 21
| 84
| 8.398438
| 58
| 24
| 35.79688
| null | 2.199707
| 0.899902
| 0.599976
| 133
| null | null | 10
| null | null | 6
|
<2 mo. follow-up
| 6
| 22
| 1
|
66.62299
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
>$50k
| 0
| 53,890
| 10,291.6172
| 12,070.4141
| 6.5
|
white
| 17.898438
| 10
| 0.852905
| 0.80188
| 4
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 7
| 52
| 10.599609
| 100
| 22
| 36.5
| null | 2.899902
| 1.099854
| 1.799805
| 127
| null | 118
| 67
| 2,310
| 0
| 0
| null | 0
| 602
| 0
|
58.69998
|
female
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 44
| 208,373
| 61,822.5625
| 65,557
| 45.666657
|
white
| 35
| 74
| 0.335999
| 0.220978
| 6
| 0
| 0
|
no
| 0.85
| 0.85
|
dnr after sadm
| 13
| 68
| 23.097656
| 125
| 12
| 37.79688
| 395
| null | null | 0.699951
| 136
| 7.40918
| 215
| 10
| 1,950
| null | 1
|
<2 mo. follow-up
| 1
| 14
| 1
|
29.26999
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 41
| 272,792
| 110,223.438
| 120,070.438
| 45
|
hispanic
| 28.796875
| 62
| 0.69397
| 0.602905
| 7
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 9
| 105
| 14.599609
| 65
| 24
| 38.5
| null | null | null | 0.799927
| 132
| null | 89
| 17
| 2,230
| null | null |
<2 mo. follow-up
| 3.072754
| 9
| 1
|
36.26797
|
female
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 21
|
>$50k
| 41
| 262,040
| 85,402.5625
| 71,938.9375
| 39
|
white
| 28.898438
| 26
| 0.651978
| 0.552979
| 8
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 22
| 67
| 13.5
| 100
| 24
| 38.19531
| null | 3.599609
| 0.5
| 0.899902
| 136
| null | null | 9
| 1,600
| null | 0
|
no(M2 and SIP pres)
| 0
| 599
| 0
|
97.23999
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 9
| 19,291
| 10,616.0938
| 8,190.79688
| 9
|
white
| 17
| 11
| 0.761963
| 0.622925
| 1
| 0
| 1
|
no
| 0.8
| 0.06
|
no dnr
| 10
| 73
| 10.298828
| 83
| 20
| 37.09375
| 252.375
| 3.699707
| 0.5
| 1.699951
| 136
| 7.369141
| 138
| 19
| null | null | 6
|
<2 mo. follow-up
| 6
| 46
| 1
|
44.37198
|
male
| 0
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
>$50k
| 26
| 174,634
| 49,494.4375
| 42,848.5938
| 26.666656
|
white
| 29.296875
| 28
| 0.366943
| 0.248993
| 17
| 0
| 0
|
yes
| 0.6
| 0.5
|
no dnr
| 22
| 65
| 13.699219
| 80
| 27
| 37.69531
| 300
| null | null | 0.799927
| 135
| 7.419922
| null | 19
| 4,165
| null | 0
|
no(M2 and SIP pres)
| 0
| 598
| 0
|
62.06198
|
male
| 0
| 13
|
Coma
|
Coma
| 0
| 16
|
>$50k
| 9
| 105,947
| 42,417.3438
| 43,350.9062
| 43
|
white
| 25.199219
| 61
| 0.647949
| 0.587891
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 13
| 117
| 8.199219
| 108
| 22
| 36.59375
| null | null | null | 0.699951
| 139
| null | null | 5
| 2,000
| null | null |
no(M2 and SIP pres)
| 1.856934
| 598
| 0
|
57.97699
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 44
| 70,163
| 13,175.4844
| 12,544.7031
| 28
|
white
| 37.5
| 81
| 0.07399
| 0.026997
| 11
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 3
| 113
| 25.398438
| 155
| 60
| 39.69531
| 91.42188
| 1.799805
| 0.699951
| 0.799927
| 135
| 7.349609
| 262
| 14
| 5,101
| null | null |
<2 mo. follow-up
| 3.311035
| 4
| 1
|
75.96698
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 0
|
$11-$25k
| 0
| 21,141
| 8,768.1953
| 7,733.06641
| 16.5
|
white
| 17.5
| 17
| 0.80188
| 0.680908
| 1
| 0
| 0
|
yes
| 0.85
| 0.8
|
no dnr
| 7
| 105
| 6.199219
| 115
| 10
| 38
| 228
| 3
| 8.798828
| 1.599854
| 155
| 7.5
| 259
| 99
| 6,920
| 2
| null | null | 1.838867
| 593
| 0
|
71.99695
|
female
| 0
| 21
|
Coma
|
Coma
| 0
| null | null | 44
| 155,313
| 52,658.3125
| 53,115.3438
| 29.666656
|
white
| 18.597656
| 28
| 0.516968
| 0.44696
| 4
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 21
| 105
| 15.5
| 135
| 26
| 39
| 340
| null | null | 0.799927
| 125
| 7.529297
| 114
| 16
| 4,950
| null | null | null | 2.020996
| 360
| 1
|
31.403
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 21
|
>$50k
| 44
| 84,726
| 31,389.7344
| 35,480.8438
| 25.666656
|
white
| 35.195313
| 51
| 0.550903
| 0.437988
| 3
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 14
| 99
| 11.898438
| 76
| 24
| 36.39844
| null | null | null | 1.199951
| 133
| null | 131
| 19
| 1,400
| null | null | null | 2.734375
| 590
| 0
|
59.87097
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 20,640
| 8,659.2891
| 9,405.875
| 11
|
white
| 19.5
| 19
| 0.791992
| 0.560913
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 6
| 102
| 0.049995
| 65
| 24
| 36.39844
| 452
| null | 1.5
| 0.699951
| 130
| 7.489258
| null | 16
| 3,400
| null | null |
no(M2 and SIP pres)
| 2.047852
| 381
| 1
|
71.12897
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 13
|
$11-$25k
| 37
| 57,493
| 14,015.8281
| 13,624.9297
| 16
|
white
| 26.5
| 34
| 0.530884
| 0.330994
| 5
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 8
| 58
| 14.099609
| 115
| 28
| 38
| 415
| null | 1.299805
| 1.899902
| 135
| 7.40918
| 301
| 30
| 1,640
| null | null |
Coma or Intub
| 3.345215
| 116
| 1
|
69.19397
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 23,046
| 12,267.5391
| 10,595.7656
| 16
|
white
| 29.199219
| 32
| 0.644897
| 0.464966
| 1
| 0
| 0
|
yes
| 0.9
| 0.75
|
dnr after sadm
| 3
| 133
| 19.898438
| 155
| 33
| 37.89844
| 177.53125
| 2.399902
| 18.199219
| 2.199707
| 144
| 7.449219
| null | 85
| 2,665
| 0
| 4
| null | 4
| 586
| 0
|
64.02197
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| null | null | 26
| 50,669
| 19,166.1562
| 23,070.0469
| 29
|
white
| 26.5
| 26
| 0.534912
| 0.211975
| 1
| 0
| 0
|
metastatic
| 1
| 0.65
|
no dnr
| 12
| 71
| null | 82
| 20
| 36
| 278.25
| null | null | 1
| 131
| 7.449219
| null | 18
| 4,875
| null | null | null | 3.33252
| 586
| 0
|
71.49097
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 136,072
| 23,399.875
| 29,611.5938
| 32.5
|
black
| 30.699219
| 39
| 0.344971
| 0.227997
| 12
| 0
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 13
| 75
| 22.597656
| 75
| 11
| 38.59375
| 455
| null | null | 0.599976
| 142
| 7.55957
| 150
| 15
| 840
| null | null | null | 3.057617
| 146
| 1
|
45.19598
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 26
| 481,895
| 84,690.4375
| 85,551.75
| 34.25
|
white
| 28.199219
| 49
| 0.649902
| 0.550903
| 29
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 27
| 62
| 2.199707
| 115
| 56
| 36.19531
| 193.875
| null | 2.599609
| 0.799927
| 134
| 7.439453
| 171
| 12
| 8,210
| null | null | null | 2.964844
| 169
| 1
|
28.627
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 30,279
| 16,035.2812
| 14,558.2891
| 17.5
|
hispanic
| 30.398438
| 29
| 0.855957
| 0.762939
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 8
| 85
| 15.298828
| 120
| 14
| 38.59375
| null | null | null | 0.899902
| 137
| null | 136
| 12
| 850
| 0
| 0
| null | 0
| 583
| 0
|
54.14099
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 13,221
| 6,602.8633
| 6,746.19922
| 16
|
white
| 21.699219
| 37
| 0.796997
| 0.67395
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 5
| 98
| 17.097656
| 135
| 39
| 36.5
| 225.6875
| null | null | 1
| 130
| 7.389648
| 224
| 23
| 2,487
| null | null | null | 3.075684
| 64
| 1
|
46.04199
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 15,981
| 6,897.0938
| 6,455.27734
| 11
|
white
| 17.5
| 12
| 0.842896
| 0.655884
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.6
|
no dnr
| 6
| 51
| null | 95
| 20
| 35.89844
| null | null | null | 1.699951
| 128
| null | null | 27
| 2,750
| null | null | null | 1.983887
| 449
| 1
|
71.19495
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 141,913
| 24,841.4375
| 23,073.8125
| 13
|
white
| 30.699219
| 47
| 0.46698
| 0.347961
| 28
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr before sadm
| -27
| 72
| 14.099609
| 125
| 32
| 37.89844
| 183.65625
| 3.299805
| null | 1.399902
| 140
| 7.169922
| 196
| 13
| 2,140
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 580
| 0
|
60.25998
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 23,886
| 11,874.4375
| 10,298.6094
| 6.5
|
white
| 21
| 20
| 0.634888
| 0.323975
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 7
| 50
| 7.199219
| 75
| 8
| 36.39844
| 187.5
| null | null | 3.399902
| 149
| 7.529297
| 138
| 93
| 2,970
| null | null | null | 3.341797
| 525
| 1
|
68.68695
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 7,975
| 4,697.3516
| 4,011.48828
| 12
|
white
| 15.5
| 19
| 0.893921
| 0.821899
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 5
| 113
| 11.5
| 110
| 32
| 36.69531
| 176
| 2.299805
| 2.099609
| 1.5
| 132
| 7.449219
| 173
| 23
| 3,785
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 257
| 1
|
58.741
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 33,382
| 15,641.9766
| 17,240.6719
| 26.5
|
white
| 20.097656
| 27
| 0.87793
| 0.795898
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 9
| 47
| 8.199219
| 105
| 20
| 35.79688
| null | 3.799805
| 2.699707
| 1.299805
| 130
| null | 112
| 17
| 3,650
| 3
| 4
| null | 4
| 172
| 1
|
71.89294
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 31
|
>$50k
| 0
| 4,750
| 2,242.2637
| 3,116.61914
| 8
|
white
| 17.398438
| 22
| 0.868896
| 0.781982
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 4
| 83
| 8
| 80
| 16
| 37
| null | 2.899902
| 8.898438
| 1.299805
| 132
| null | null | 21
| 760
| null | null |
no(M2 and SIP pres)
| 2.151856
| 578
| 0
|
62.34399
|
male
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 145,561
| 81,578.1875
| 66,213.625
| 24.666656
|
white
| 25.597656
| 37
| 0.754883
| 0.611938
| 1
| 0
| 0
|
yes
| 0.75
| 0.7
|
no dnr
| 17
| 93
| 6.599609
| 126
| 24
| 38.39844
| null | null | 0.799927
| 0.899902
| 140
| null | 113
| 9
| 3,975
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 577
| 0
|
60.66299
|
female
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 41
| 233,830
| 57,363.3438
| 61,455.9375
| 52
|
white
| 53.59375
| 97
| 0
| 0
| 17
| 0
| 0
|
yes
| 0.1
| 0.1
|
dnr after sadm
| 5
| 100
| 0.899902
| 110
| 24
| 36.19531
| 218.34375
| null | null | 0.899902
| 130
| 7.529297
| null | 17
| 3,800
| null | null |
<2 mo. follow-up
| 2.802246
| 9
| 1
|
50.40097
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
| null | 0
| 81,871
| 11,551.2188
| 12,517.5859
| 15.5
|
other
| 16.699219
| 20
| 0.903931
| 0.868896
| 3
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 7
| 77
| 12.099609
| 114
| 24
| 36
| null | null | null | null | 140
| null | null | null | 1,550
| null | null | null | 1.853027
| 576
| 0
|
51.52399
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 14
| null | 0
| 21,235
| 9,458.8828
| 10,376.3281
| 18.5
|
white
| 22.5
| 28
| 0.622925
| 0.30896
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr before sadm
| -1
| 72
| null | 75
| 16
| 36.5
| null | null | null | 1.5
| 142
| null | null | 26
| 3,855
| null | null |
<2 mo. follow-up
| 3.532715
| 17
| 1
|
52.71698
|
male
| 1
| 8
|
Coma
|
Coma
| 1
| 20
|
>$50k
| 44
| 75,660
| 27,551.9062
| 27,582.4375
| 33
|
black
| 26.296875
| 46
| 0.521973
| 0.450989
| 2
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 8
| 50
| 6.199219
| 75
| 20
| 36.79688
| null | null | null | 1.199951
| 137
| null | null | 35
| 3,185
| null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
64.64899
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 29,507
| 15,344.5391
| 13,907.7734
| 12
|
white
| 12.298828
| 15
| 0.789917
| 0.557983
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 10
| 73
| 8.099609
| 70
| 20
| 36
| null | null | null | 1.599854
| 141
| null | null | 30
| 3,300
| null | null |
no(M2 and SIP pres)
| 2.89502
| 392
| 1
|
73.51996
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 13,121
| 6,902.6875
| 7,288.84766
| 13.5
|
white
| 14.898438
| 18
| 0.828979
| 0.628906
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 68
| 35.898438
| 120
| 28
| 36
| null | null | null | 1.199951
| 136
| null | null | 21
| 2,790
| null | null | null | 2.86084
| 291
| 1
|
63.685
|
female
| 1
| 20
|
Coma
|
Coma
| 3
| 11
|
$11-$25k
| 100
| 207,959
| 77,106.6875
| 86,680.125
| 30.666656
|
white
| 36.796875
| 66
| 0.003
| 0.001
| 2
| 0
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 18
| 52
| 0.049995
| 105
| 10
| 35.69531
| 131
| null | 15.099609
| 3.099609
| 142
| 7.239258
| 326
| 32
| 0
| null | 3
|
<2 mo. follow-up
| 3
| 20
| 1
|
66.33295
|
male
| 0
| 118
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 26
| 933,220
| 373,073
| 355,017.75
| 47.25
|
white
| 25.796875
| 53
| 0.656982
| 0.55896
| 3
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 118
| 62
| 7.799805
| 100
| 36
| 38.29688
| 315
| null | null | 0.799927
| 136
| 7.449219
| null | 13
| 2,430
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 181
| 1
|
38.76498
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 37
| 143,626
| 54,987.5312
| 60,904.0938
| 50
|
white
| 26.699219
| 36
| 0.760986
| 0.684937
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 10
| 61
| 5.5
| 116
| 12
| 36.19531
| null | null | null | 0.699951
| 143
| null | null | 9
| 1,550
| null | 0
| null | 0
| 202
| 1
|
65.55798
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 21
|
$11-$25k
| 0
| 9,123
| 4,302.4062
| 5,463.01953
| 10
|
white
| 19.296875
| 34
| 0.768921
| 0.632935
| 1
| 1
| 0
|
no
| 1
| 0.9
|
no dnr
| 6
| 122
| 110
| 55
| 14
| 38.69531
| 165
| null | null | 2
| 143
| 7.469727
| 281
| 25
| 2,380
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 540
| 1
|
46.56
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
>$50k
| 41
| 149,633
| 33,083.8438
| 36,292.4375
| 46.5
|
white
| 47.195313
| 85
| 0.100998
| 0.042
| 8
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 6
| 72
| 6.199219
| 76
| 20
| 37.79688
| null | null | null | null | 140
| null | null | null | 1,850
| null | 2
|
<2 mo. follow-up
| 2
| 10
| 1
|
67.89294
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$25-$50k
| 44
| 269,491
| 54,600.3438
| 57,670.75
| 42.666657
|
white
| 22.296875
| 37
| 0.634888
| 0.532959
| 5
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 20
| 76
| 9.398438
| 72
| 20
| 36
| null | null | 0.399963
| 1.099854
| 141
| null | null | 18
| 1,400
| null | 0
|
no(M2 and SIP pres)
| 0
| 279
| 1
|
58.24197
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 11,848
| 5,331.1211
| 5,571.59766
| 9
|
white
| 45.695313
| 29
| 0.145996
| 0.008999
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 1
| 92
| 3.399902
| 105
| 26
| 36
| null | 1.5
| 17
| 2.099609
| 126
| null | 84
| 66
| 875
| null | null |
adl>=4 (>=5 if sur)
| 2.475098
| 88
| 1
|
68.65997
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 71,707
| 10,469.6094
| 13,937.4844
| 40
|
white
| 24.898438
| 25
| 0.753906
| 0.675903
| 3
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 4
| 60
| 25.199219
| 105
| 28
| 38
| 332.5
| null | null | 3.199707
| 142
| 7.489258
| 212
| 49
| 585
| null | 0
| null | 0
| 567
| 0
|
53.49197
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 4
|
under $11k
| 41
| 199,060
| 58,617.875
| 60,350.5625
| 42.5
|
hispanic
| 39.195313
| 71
| 0.346985
| 0.230988
| 1
| 0
| 0
|
no
| 0.1
| 0.05
|
no dnr
| 13
| 65
| 9.398438
| 95
| 6
| 36.29688
| 455
| null | 6.899414
| 1.899902
| 149
| 7.539062
| 73
| 53
| 2,945
| null | 5
|
<2 mo. follow-up
| 5
| 15
| 1
|
70.71295
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 35,262
| 15,618.2266
| 18,277.7969
| 17
|
white
| 11.798828
| 15
| 0.86792
| 0.703979
| 1
| 0
| 0
|
metastatic
| 1
| 0.95
|
no dnr
| 10
| 77
| 4.799805
| 78
| 20
| 35.69531
| null | 3.899902
| 3
| 1.5
| 138
| null | 111
| 31
| 1,825
| null | null | null | 2.425781
| 563
| 0
|
68.73895
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 41
| 58,336
| 22,046.9688
| 23,853.125
| 39
|
white
| 44.898438
| 101
| 0.085999
| 0.032997
| 2
| 1
| 0
|
no
| 0.05
| 0.05
|
dnr after sadm
| 4
| 52
| 6.599609
| 115
| 40
| 38.59375
| 270
| null | 46
| 3.699707
| 143
| 7.449219
| 340
| 95
| 424
| null | null |
<2 mo. follow-up
| 2.916016
| 4
| 1
|
60.87097
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 3
| null | null | 0
| 11,670
| 4,700.5703
| 5,847.15625
| 18
|
white
| 16.199219
| 17
| 0.833984
| 0.637939
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.2
|
no dnr
| 5
| 65
| 6.599609
| 75
| 8
| 38
| null | 3.299805
| 3
| 3.5
| 135
| null | 106
| 101
| 3,360
| null | null | null | 3.194336
| 187
| 1
|
77.14398
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 9
| 328,863
| 67,441.9375
| 68,026.9375
| 27.333328
|
white
| 35.695313
| 80
| 0.362
| 0.244995
| 1
| 1
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 24
| 74
| 9.099609
| 110
| 18
| 36
| null | 2
| 0.299988
| 0.699951
| 120
| null | 84
| 8
| 900
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 560
| 0
|
61.92999
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 8
|
under $11k
| 0
| 7,500
| 3,849.8496
| 4,052.82812
| 11
|
hispanic
| 19
| 23
| 0.795898
| 0.671997
| 1
| 1
| 0
|
no
| 0.5
| 0
|
no dnr
| 6
| 72
| 8.099609
| 55
| 20
| 36.19531
| 91.65625
| null | 0.599976
| 1.399902
| 138
| 7.419922
| null | 26
| 1,636
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 559
| 0
|
43.05798
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 94,436
| 28,478.7031
| 27,283.9844
| 15.666664
|
white
| 22.398438
| 19
| 0.85498
| 0.804932
| 7
| 0
| 0
|
no
| 0.5
| 0.1
|
no dnr
| 15
| 70
| 26.097656
| 110
| 28
| 35.5
| 302.5
| null | 22.597656
| 2.199707
| 133
| 7.349609
| 223
| 77
| 1,885
| null | null |
no(M2 and SIP pres)
| 2.992676
| 555
| 0
|
54.47998
|
male
| 0
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 19,860
| 8,709
| 8,849.10938
| 14
|
white
| 23.296875
| 16
| 0.664917
| 0.567993
| 1
| 1
| 0
|
metastatic
| 0.05
| 0.01
|
no dnr
| 6
| 65
| 8.599609
| 75
| 24
| 38.09375
| null | null | 0.5
| 1.199951
| 138
| null | 95
| 18
| 4,085
| 0
| null | null | 0.494751
| 104
| 1
|
80.323
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 26
| 51,079
| 21,268.8438
| 20,973.2188
| 32.5
|
white
| 27.398438
| 70
| 0.574951
| 0.464966
| 1
| 1
| 1
|
no
| 0.7
| 0.5
|
dnr after sadm
| 3
| 99
| 7
| 79
| 28
| 36.39844
| 252.375
| null | null | 0.799927
| 137
| 7.449219
| 95
| 15
| 1,925
| null | null |
<2 mo. follow-up
| 6.46582
| 49
| 1
|
32.28198
|
male
| 1
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
under $11k
| 44
| 226,262
| 59,380.7188
| 61,909.5
| 41.5
|
hispanic
| 29
| 49
| 0.314941
| 0.201996
| 13
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 11
| 52
| 28.398438
| 70
| 34
| 35.79688
| 184
| 2.299805
| 27.699219
| 4.5
| 145
| 7.449219
| 207
| 66
| 35
| null | 0
|
<2 mo. follow-up
| 0
| 13
| 1
|
44.73099
|
male
| 1
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
| null | 0
| 800,959
| 216,988.875
| 202,004
| 48.25
|
white
| 29.398438
| 43
| 0.717896
| 0.631958
| 50
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 33
| 109
| 6.199219
| 85
| 28
| 36.59375
| 313.3125
| null | null | 1
| 134
| 7.459961
| 154
| 16
| 3,350
| null | 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
49.44598
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 61
| 53,642
| 24,402.3594
| 24,352.9531
| 53
|
hispanic
| 41
| 93
| 0.144989
| 0.068985
| 1
| 0
| 0
|
yes
| null | null |
dnr before sadm
| 0
| 60
| 29
| 120
| 24
| 36
| 120
| null | 3.099609
| 8.5
| 142
| 7.429688
| 146
| 89
| 55
| null | null |
<2 mo. follow-up
| 4.116211
| 8
| 1
|
68.07098
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
|
$11-$25k
| 9
| 96,931
| 27,934.3906
| 26,548.6562
| 27
|
white
| 28.199219
| 39
| 0.589966
| 0.480957
| 3
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 12
| 71
| 4.699219
| 78
| 20
| 36.79688
| null | null | 1.599854
| 1.199951
| 127
| null | 282
| 30
| 2,100
| null | null | null | 2.520996
| 547
| 0
|
61.71899
|
male
| 0
| 28
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 205,874
| 110,087.375
| 88,449.4375
| 27.5
|
white
| 21.296875
| 36
| 0.85791
| 0.764893
| 1
| 1
| 0
|
no
| 0.92
| 0.85
|
no dnr
| 28
| 75
| 20.898438
| 104
| 30
| 38.59375
| 173.3125
| null | 1.099854
| null | 138
| 7.479492
| null | null | 2,050
| 1
| null | null | 1.166748
| 543
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.